FDA Inspection
BNP Industries Inc. dba Savannah SoapsBNP Industries Inc. dba Savannah Soaps – FDA Inspection, Jul 12, 2017
Record Details
This FDA Inspection record concerns BNP Industries Inc. dba Savannah Soaps, with an inspection on July 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Ivy E. Sweeney (Issuing Officer)
- Lillie D. Witcher (Company Rep)
View Company Profile
ID · fd848464-4f55-4b46-95e7-6c98ff1afdfa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017610
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
9- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.25(a)Training--operations, GMPs, written procedures
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.130Procedures are written, and followed
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.80(a)Procedures To Be in Writing
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.